July 27, 2026
A new study from the Neiman Institute found that the persistent declines in Medicare physician reimbursement are associated with widening disparities in access to care, with patients in rural communities, low-income areas, and disadvantaged neighborhoods falling further behind their more urban, affluent, and advantaged counterparts. The study, based on 4.7 million unique patients over the 2005-2023 period, was published in INQUIRY: The Journal of Health Care Organization, Provision, and Financing. Read More
June 26, 2026
A new study published in the American Journal of Neuroradiology finds that adoption of artificial intelligence software for detecting large vessel occlusion in acute ischemic stroke when billed through Medicare’s New Technology Add-On Payment program has grown but remains uneven, with use concentrated in larger, specialized hospitals and varying geographically. Read More
June 24, 2026
Radiologists performing no interventional radiology-related work increased from one-third in 2008 to one-half in 2023. These findings, based on a national Medicare analysis of 46,533 radiologists covering 476,688 radiologist years from 2008 to 2023 period, were published in the JVIR by the HPI in collaboration with IR experts. Read More
May 13, 2026
An artificial intelligence algorithm for pulmonary embolism detection demonstrated high concordance with radiologist interpretations in a large, real-world study published today in Radiology: Artificial Intelligence. Read More
April 30, 2026
A new study from the Neiman Institute found that the introduction of PET-based Gallium-68 DOTATATE/DOTATOC radiotracers for imaging neuroendocrine tumors created substantial differences in patient access during its first four years of use. Compared with the older imaging agent, Indium-111 pentetreotide (Octreoscan™), patients in small town-rural areas traveled 134.9 additional miles on average to access Gallium-68 DOTATATE/DOTATOC. The study, published in JACR, analyzed 3,365 claims for neuroendocrine tumor radiotracers. Read More
